All Updates

All Updates

icon
Filter
Funding
ChargePoint secures USD 232 million in equity funding
EV Economy
Oct 11, 2023
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Oct 11, 2023

ChargePoint secures USD 232 million in equity funding

Funding

  • ChargePoint, an NYSE-listed EV charging solutions provider, has secured USD 175M in new equity funding from institutional investors through its at-the-market (ATM) offering facility. The company also raised USD 57 million in additional funds through the same facility in Q3 FY2024.

  • The funds raised will support ChargePoint's goal of achieving adjusted EBITDA profitability in Q4 FY2024. 

  • Analyst QuickTake: This funding announcement follows ChargePoint securing a USD 150 million revolving credit facility in July 2023 . J.P. Morgan Chase Bank acted as the Administrative Agent and Joint Lead Arranger, while HSBC Innovation Banking was the Joint Lead Arranger, and Citi and Goldman Sachs were Documentation Agents. The company intended to use the funds toward its aim of having a positive adjusted EBITDA and positive cash flow by Q4 FY2024.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.